Cardiotrophin-1 (Digna Biotech/Biotecnol)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCardiotrophin-1 (Digna Biotech/Biotecnol)
Drug Alias NameCT-1
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionApoptosis inhibitors
TargetsLeukemia inhibitory factor receptor
Therapy Area/IndicationsIschemiaMyocardial Reperfusion InjuryAcute Kidney Injury +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsIschemiaMyocardial Reperfusion InjuryAcute Kidney Injury
Inactive IndicationsLiver Failure

Other Information

ATC CodeN/A
Related LinksN/A